Scientific Committee

Scientific Chair: Paul Terrill (Cytel UK), Conference Chair: Kate Taylor (Amgen)

The Scientific committee organises a number of one-day scientific meetings, webinars and the annual conference as well as joint meetings with other professional bodies each year. The topics of these meetings include statistical techniques and applications in pre-clinical and clinical trials, specific therapeutic areas, health technology assessments as well as regulatory and management issues.

Meetings

The Scientific Committee meets each month and alternates between teleconferences and face to face meetings primarily in London or the surrounding area.

Composition

The Scientific Committee is composed of the following members

Adam Crisp (GlaxoSmithKline)
Amitava Mukhopadhyay (Cytel India)
David Lawrence (Novartis)
Emanuella Pozzi (Roche)
Ioulietta Mulligan (Worldwide Clinical Trials)
Jennifer Gilbride (GlaxoSmithKline)
Julia Saperia (MHRA)
Kate Taylor (Amgen)  
Lynsey Womersley (Phastar)
Maria Efstathiou (IQVIA)
Martin Jenkins (AstraZeneca)
Mouna Akacha (Novartis)
Paul Terrill (Cytel UK)
Rachael Lawrance (Adelphi Values) 
Rosie Leach (Numerus)
Russell Jones (Orchard Therapeutics)
Sarah Williams (Roche)
Sue Todd (Reading University)
Tobias Mütze (Novartis)
Tom Burnett (Lancaster University)
 

EventsFuture Events


  • PSI Webinar: Adaptive design: updated draft FDA guidance and its implications - Dates: 11 – 11 Jun, 2019

    In September 2018 the FDA published a guidance on adaptive design for clinical trials of drugs and biologics, updating (not finalizing) its initial draft from February 2010. The main focus of the webinar will be to provide an overview of its main contents, which will be presented by Jürgen Hummel (PPD). In addition, Kaspar Rufibach (Roche) will introduce an open-source statistical software for adaptive designs, RPACT (an R package that enables the design and analysis of confirmatory adaptive clinical trials). Kit Roes will also comment on the guidance from a European Regulatory perspective, which will be followed by a brief panel discussion.
  • Adaptive Designs - Dates: 24 – 24 Jun, 2019

    During this meeting we will hear about adaptive sample allocation for phase II/III designs, a new CONSORT extension reporting guideline for adaptive designs, regulatory aspects and case studies.
Pharm Research Associates

Principal Biostatistician

read more...

Autolus Therapeutics

Head of Statistical and Data Innovation as Head of Biometrics

read more...

Laegemiddelstyrelsen_UK_360x180_jobzonen-og-jobfinder

Leading Biostatistician with experience in Big Data and advanced analytics

read more...

Laegemiddelstyrelsen_UK_360x180_jobzonen-og-jobfinder

Biostatistician with experience in clinical drug development

read more...

bayerlogoresized

Statistician Opportunities in the UK

read more...